|
HS Code |
804977 |
| generic_name | Atropine Sulfate |
| drug_class | Anticholinergic |
| chemical_formula | C17H23NO3·H2SO4 |
| route_of_administration | Intravenous, Intramuscular, Subcutaneous, Ophthalmic |
| indications | Bradycardia, Organophosphate poisoning, Pre-anesthetic medication, Mydriasis induction |
| mechanism_of_action | Blocks acetylcholine at muscarinic receptors |
| dosage_form | Injection, Eye drops |
| onset_of_action | Within minutes (IV), 30-40 minutes (IM) |
| half_life | 2–4 hours |
| contraindications | Glaucoma, Myasthenia gravis, Prostatic hypertrophy |
| side_effects | Dry mouth, Blurred vision, Tachycardia, Urinary retention |
As an accredited Atropine Sulfate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Atropine Sulfate is packaged in a 10 mL clear glass vial, labeled with dosage, concentration (0.6 mg/mL), and manufacturer details. |
| Shipping | Atropine Sulfate is shipped as a hazardous chemical under tightly sealed, labeled containers to prevent contamination and degradation. Transportation must comply with regulations for toxic substances, ensuring temperature control and protection from light. Proper documentation, including safety data sheets and hazard labels, is mandatory to guarantee safe and compliant delivery. |
| Storage | Atropine Sulfate should be stored in a tightly closed container, protected from light, moisture, and excessive heat, at a controlled room temperature (20°C to 25°C or 68°F to 77°F). It should be kept away from incompatible substances and out of reach of children. Ensure proper labeling and store in a secure area according to regulatory requirements, especially in healthcare settings. |
| Purity 98%: Atropine Sulfate Purity 98% is used in ophthalmic examinations, where it ensures reliable pupil dilation and consistent diagnostic results.Melting Point 190°C: Atropine Sulfate Melting Point 190°C is used in pharmaceutical manufacturing, where it provides thermal stability during tablet formulation.Molecular Weight 694.83 g/mol: Atropine Sulfate Molecular Weight 694.83 g/mol is used in injectable solutions, where it guarantees precise dosing and predictable pharmacokinetics.Stability Temperature 25°C: Atropine Sulfate Stability Temperature 25°C is used in hospital emergency kits, where it maintains long-term efficacy and rapid therapeutic response.Particle Size ≤ 10 μm: Atropine Sulfate Particle Size ≤ 10 μm is used in parenteral preparations, where it achieves rapid dissolution and uniform drug delivery.Water Solubility 100 mg/mL: Atropine Sulfate Water Solubility 100 mg/mL is used in intravenous formulations, where it enables complete solution preparation and efficient patient administration.pH Range 4.0–5.5: Atropine Sulfate pH Range 4.0–5.5 is used in sterile ophthalmic solutions, where it ensures compatibility with ocular tissues and minimizes irritation.Assay ≥ 99.0%: Atropine Sulfate Assay ≥ 99.0% is used in clinical anesthesiology, where it assures accurate drug potency and optimal preoperative management.Endotoxin Level < 0.25 EU/mg: Atropine Sulfate Endotoxin Level < 0.25 EU/mg is used in injectable drug products, where it minimizes immunogenic response and enhances patient safety. |
Competitive Atropine Sulfate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Atropine Sulfate attracts a lot of attention in the world of critical care. It stands out not just because of its well-known place in hospital crash carts, but for the tangible difference it makes in both daily clinical medicine and urgent situations. As a healthcare writer and a volunteer EMT, I have run across this medication countless times. Having a dependable supply of it brings peace of mind—whether you are an emergency responder, an anesthetist in an operating room, or part of a rural medical team miles from the nearest trauma center. The 1 mg/mL injection, usually available in 1 mL or 10 mL vials, connects the user directly to a tool with a decades-long track record behind it.
Looking at atropine as just another anticholinergic agent does not do it justice. Clinically, it brings forth the opportunity to restore and stabilize a person’s heart rhythm—something that can mean the difference between life and death in emergencies like symptomatic bradycardia. Often, it steps into the void when a patient’s heart threatens to slow down dangerously. Atropine acts by blocking acetylcholine on muscarinic receptors at nerve endings. That detail translates into a real benefit: it raises heart rate quickly without the need for fancy technology or lengthy preparation. In rural or resource-limited settings, I have seen it avert cardiac arrest, buying precious time until advanced support arrives.
No other drug fills the same gap quite the way atropine does, despite the presence of newer or complementary agents like epinephrine or dopamine. For starters, atropine’s role in acute bradyarrhythmia is nearly universally acknowledged. The 1 mg/mL, 1 mL single-use vial offers an immediately usable dose for adults. Pediatric care requires much more careful calculation—generally 0.02 mg/kg, never less than 0.1 mg, but always with the vial ready at the bedside for quick draw-up. These details matter to every clinician who handles code blue events, acute poisoning cases, or perioperative anesthesia. They also matter to patients, who simply want to know their team can act with speed and precision.
Atropine Sulfate establishes its worth in two distinct ways: response to bradyarrhythmias and treatment of certain toxic exposures. Beyond the emergency frame, it is also pivotal during anesthesia, especially with airway management in children or when excessive secretions threaten the airway. Each of these uses calls for accuracy—an exact dose, pushed or titrated with awareness of age, weight, and comorbidities. Over the years, atropine’s reliability has shaped how clinicians approach pesticide or nerve agent poisoning as well, serving as the centerpiece of rapid atropinization protocols. Its ability to counteract muscarinic effects, particularly in high-exposure scenes, creates a path for triage and survival that nothing else quite matches.
Even with discussion swirling in medical conferences about alternatives and algorithm updates, the real-world confidence professionals place in this medication is built on deep experience. Time in the field has taught me that no protocol ever replaces hard-earned trust in a medication that consistently delivers—especially one that's easy to teach and safe to use when time is tight. Friends who work in the military and disaster medicine also share similar stories. Having atropine sulfate on hand remains an essential point in readiness checklists, not just for isolated incidents but for public health preparedness on a national scale.
Across various settings, the standard 1 mg/mL ampoule, sealed and light-protected, ensures preservation of potency and straightforward drawing without complex preparation. Many providers also prefer the 0.4 mg/mL or 0.6 mg/mL versions for specific pediatric or incremental dosing. Key to its widespread use is the medication’s simple, predictable concentration, which rules out confusion during a high-stress resuscitation. During clinical rotations, instructors drilled it into us: always check the label, know the vial volume, and waste nothing. That habit stuck, and for every emergency kit I have ever assembled since, I reach for the form most likely to help in urgent intravenous or intramuscular administration.
Unlike some drugs that require dilution or careful compounding, prefilled syringes and ampoules make Atropine Sulfate an easier choice. With fewer steps between decision and action, everybody—from seasoned surgeons to new paramedics—appreciates being able to deliver an exact dose in seconds. This specific, ready-injection model surpasses older or multi-use containers, which risk dosing errors in the chaos of an emergency. While mistakes are rare, they can prove catastrophic with medications affecting cardiac rhythm, so packaging that minimizes extra handling adds a layer of safety grounded in real outcomes. These details, often overlooked outside hospital supply rooms, end up shaping patient care in ways that become clear only during the moments that matter most.
Atropine Sulfate often gets compared to other drugs used in bradycardia or organophosphate poisoning, such as glycopyrrolate or pralidoxime. Each has its role, but none replace atropine’s unique blend of speed, availability, and clear dosing. Glycopyrrolate, for example, shows slower action in raising heart rate and lacks effectiveness in acute neurotoxin poisoning. Pralidoxime, meanwhile, plays more of a supportive role—helping reactivate cholinesterase after nerve agent exposure, but always in tandem with atropine rather than instead of it.
The direct, positive impact of atropine becomes obvious during resuscitation or toxidrome scenarios. Its rapid onset, straightforward preparation, and lack of need for specialized handling outpace most alternatives. You might find debate about ideal first-line agents for some conditions, but decades of data continue pointing to atropine’s success rate and low complication profile in the scenarios discussed above. Its compatibility with other cardiac medications, and its safety with repeated dosing in certain poisoning cases, carve out a reputation that goes further than just tradition or convenience—it's built on outcome studies reviewed by international cardiac and toxicology panels.
Using atropine responsibly means knowing both its strengths and its side effect profile. While minor complaints like dry mouth or blurred vision occasionally arise, these pale in comparison to the risks of untreated bradycardia or cholinergic crisis. Caution grows necessary in elderly patients, or those with underlying glaucoma, heart rhythm disturbances, or suspected obstructive uropathy. For clinicians, the knowledge needed to weigh these risks and time the dosing right comes from hands-on experience, thorough study, and support from nursing and pharmacy teams. Whenever the medication comes up in a patient scenario, it prompts a quick check on history and ongoing monitoring—especially for arrhythmia, worsening symptoms, or paradoxical bradycardia if the dose runs too low in pediatric use.
Healthcare providers benefit when manufacturers continue to improve labeling and education around atropine, but the reality is nearly every nurse, doctor, or paramedic using the drug has it imprinted deep in memory after just a few real-life cases. The experiences become shorthand for future reference. It is not uncommon to see teams run through mock codes or debrief after a tough call and discover that it is small details—having the concentration clearly marked, the vial easy to open, the administration route simple—that make the real-world difference. Medication errors do happen, and processes like double-checking and color-coded labeling for atropine have cut them down even further, backed by consistent regulatory review and international medication safety groups.
Drawing from firsthand insight, greater access and newer delivery forms can extend atropine’s possibilities even further. Emergency packs with stabilized, auto-injector devices allow first responders, police, and even civilians to respond confidently to mass casualty events or agricultural accidents. These compact formats, sometimes bundled with antidotes for industrial accidents, make distribution and deployment much easier in remote or resource-starved regions. Increased community training on how and when to use atropine, especially in agricultural communities exposed to certain pesticides, could close care gaps left by limited hospital capacity. Some tech-friendly regions have begun piloting apps or pocket guides tailored for rural clinicians, giving instant dosing calculators and safety checks to those with a phone but no specialist backup. Programs like these can multiply the real-world impact of this time-tested medication.
Cost and supply stability continue to matter. Shortages, which have happened more than once in the last decade due to manufacturing hiccups or distribution issues, can leave emergency providers scrambling. National medical societies and procurement groups now recommend maintaining reserve stock, transparent tracking, and improved supply chain visibility for critical medications like atropine. This ensures not only patient safety but also peace of mind for providers who see the medication as a mainstay, not a luxury. Pharmaceutical companies are being pressed to invest in extra manufacturing capacity for drugs like atropine, not because of their profitability, but because society cannot afford to go without them. Advocates in public health and emergency medicine circles continue to push for these measures at the policy and operational level.
Beyond the clinical and regulatory realms, atropine sulfate touches lives in ways that rarely make it into case studies or news reports. In parts of the world where accidental or intentional exposure to nerve agents or insecticides remains a threat, the community’s comfort with antidote access means more than any abstract preparedness metric. Pharmacists, primary care teams, and field medics often become first teachers for families and community leaders, ensuring that even those without formal medical education understand what to do if time is short and help is far away. As a writer who has sat with volunteer responders during regional training, I have seen firsthand the gratitude and confidence that a simple, available, life-saving medicine can foster. The story of atropine’s impact is not just a series of studies or algorithm updates, but one of trust, education, and shared responsibility.
Looking back across my career and experiences in emergency and community medicine, Atropine Sulfate holds a place of respect among clinicians and patients alike. Its practical advantages—precise manufacture, clear dosage, reliable efficacy—set it apart from similar agents. The stories of lives protected, crises averted, and rural clinics brought just a little closer to big-city resources all circle back to its presence on the shelves. The trends lean toward even broader, more accessible forms, but the core value runs much deeper. Atropine Sulfate represents what every essential medicine tries to achieve: trust built over time, effectiveness proven in chaos, and a safety profile refined by both data and human experience. The more we invest in access, training, and awareness for lifesaving tools like this, the better we all fare—not just as individual patients or providers, but as a collective striving to make healthcare safer and more responsive.